Sulfasalazine Market Sulfasalazine is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It contains two drugs combined — sulfapyridine and 5-aminosalicylic acid. Sulfasalazine works by blocking some of the body's immune response, reducing inflammation and helping control flare-ups of bowel disease. It comes in tablet form and is generally well-tolerated, with common side effects including nausea, vomiting, headache and rash. The global sulfasalazine market is estimated to be valued at US$ 2.32 Billion in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024-2031 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The increasing prevalence of autoimmune and inflammatory disorders represents a major market opportunity for sulfasalazine. According to studies, autoimmune disorders affect nearly 24 million Americans annually. Conditions like rheumatoid arthritis, ulcerative coli...